BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7567941)

  • 1. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.
    Dalal P; Shousha S
    Mod Pathol; 1995 May; 8(4):413-6. PubMed ID: 7567941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.
    Jensen ML; Kiaer H; Melsen F
    Histopathology; 1996 Sep; 29(3):241-5. PubMed ID: 8884352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratins 7 and 14 in special types of invasive breast carcinomas.
    Toth T
    Med Pregl; 1999; 52(6-8):227-32. PubMed ID: 10518377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations and histological type of invasive breast carcinoma.
    Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
    Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP; Nicosia RF
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
    Wada T; Yasutomi M; Yamada K; Hashimura K; Kunikata M; Tanaka T; Huang JW; Mori M
    Anticancer Res; 1991; 11(6):1983-93. PubMed ID: 1723260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
    Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
    Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
    Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R; Mitze M; Frixen UH; Birchmeier W
    Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
    Pellegrino MB; Asch BB; Connolly JL; Asch HL
    Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
    Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
    Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vimentin expression in benign and malignant lesions in the human mammary gland.
    Wada T; Yasutomi M; Hashmura K; Kunikata M; Tanaka T; Mori M
    Anticancer Res; 1992; 12(6B):1973-82. PubMed ID: 1284196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
    Gottlieb C; Raju U; Greenwald KA
    Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of aspecific alkaline phosphatase in the intraoperative histological examination of the breast].
    Vigliani R; Iandolo M
    Pathologica; 1997 Feb; 89(1):44-53. PubMed ID: 9312732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB; Lee MW; Zarbo RJ; Crissman JD
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
    Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
    Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours.
    Bartek J; Taylor-Papadimitriou J; Miller N; Millis R
    Int J Cancer; 1985 Sep; 36(3):299-306. PubMed ID: 2411673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary carcinoma of the breast: a tumour lacking keratin 19.
    Larsimont D; Lespagnard L; Degeyter M; Heimann R
    Histopathology; 1994 Jun; 24(6):549-52. PubMed ID: 7520414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.
    Domagala W; Harezga B; Szadowska A; Markiewski M; Weber K; Osborn M
    Am J Pathol; 1993 Mar; 142(3):669-74. PubMed ID: 8384406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.